SaileGene Technologies (Beijing)
Latest round
- Angel
Last raised
- Jan 2019
Total raised
- $1.5M
Investors
- 1
About SaileGene Technologies (Beijing)
Based in Beijing, China and established in 2018, SaileGene Technologies (Beijing) Ltd. operates as a gene technology company which focuses on NGS (Next-generation sequencing). It provides devices and equipment for scientific research and disease diagnosis such as hereditary disease and cancer.
Who invested in SaileGene Technologies (Beijing)
1 investor across 1 round
See all investors in SaileGene Technologies (Beijing)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jan 1, 2019
Amount
$1.5M
Investors
Questions about SaileGene Technologies (Beijing)
Who invested in SaileGene Technologies (Beijing)?
SaileGene Technologies (Beijing) has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SaileGene Technologies (Beijing) raised?
SaileGene Technologies (Beijing) has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SaileGene Technologies (Beijing) last raise money?
SaileGene Technologies (Beijing)'s most recent round on record is a Angel, in Jan 2019.
What does SaileGene Technologies (Beijing) do?
Based in Beijing, China and established in 2018, SaileGene Technologies (Beijing) Ltd.
Where is SaileGene Technologies (Beijing) headquartered?
SaileGene Technologies (Beijing) is headquartered in Beijing, China.
Which VCs invest in companies like SaileGene Technologies (Beijing)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at SaileGene Technologies (Beijing)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like SaileGene Technologies (Beijing)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.